Abstract
IN THE utilization of isotopes to aid in the clinical management of intracranial tumors that has been developed at this hospital in the past few years, we have been aided by many workers. The time at which an elaborate addition to the hospital's investigative facilities is brought into action is perhaps a suitable time to draw attention to the diversity of talents that has been required for making some headway in such a limited field as that of brain tumors.About four years ago, when Dr. Selverstone and I were receiving our first education in the use of radioactive isotopes . . .